Top Page
Mobix Labs
(NASDAQ:MOBX)
Mobix Labs (MOBX) vs. SPDR S&P 500 ETF (SPY)
Mobix Labs Business Overview & Revenue Model
Mobix Labs Earnings Call Summary
Mobix Labs Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.98M | 6.44M | 1.22M | 3.31M | 435.00K |
| Gross Profit | 5.73M | 2.55M | -396.00K | 457.00K | 138.00K |
| EBITDA | -38.06M | -18.87M | -34.91M | -22.35M | -21.00M |
| Net Income | -41.94M | -20.03M | -39.62M | -23.87M | -19.99M |
Balance Sheet | |||||
| Total Assets | 34.55M | 39.09M | 18.75M | 15.48M | 18.88M |
| Cash, Cash Equivalents and Short-Term Investments | 240.00K | 266.00K | 89.00K | 178.00K | 1.01M |
| Total Debt | 5.67M | 4.88M | 6.68M | 4.32M | 3.41M |
| Total Liabilities | 34.13M | 33.56M | 21.79M | 24.90M | 18.95M |
| Stockholders Equity | 425.00K | 5.53M | -3.04M | -9.42M | -63.00K |
Cash Flow | |||||
| Free Cash Flow | -9.24M | -18.43M | -15.26M | -16.51M | -12.39M |
| Operating Cash Flow | -9.22M | -18.39M | -14.63M | -16.46M | -10.94M |
| Investing Cash Flow | 11.00K | -1.11M | -633.00K | 244.00K | -1.39M |
| Financing Cash Flow | 9.24M | 19.67M | 15.17M | 15.38M | 13.07M |
Mobix Labs Technical Analysis
Mobix Labs Risk Analysis
Mobix Labs Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | $146.43M | -15.40 | -24.81% | ― | -42.77% | 83.21% | |
45 Neutral | $24.42M | -43.04 | -14.79% | ― | 485.62% | 85.02% | |
44 Neutral | $98.07M | ― | -18.19% | ― | 2.80% | ― | |
44 Neutral | $74.85M | -2.01 | ― | ― | 28.31% | -239.16% | |
41 Neutral | $38.77M | -1.11 | ― | ― | -44.05% | -2.33% | |
41 Neutral | $46.65M | -0.65 | -936.03% | ― | ― | ― |
Mobix Labs Corporate Events
On October 21, 2025, Mobix Labs, Inc. entered into an At The Market Offering Agreement with Roth Capital Partners, LLC to sell up to $15.8 million in shares of its Class A common stock. The proceeds from this offering are intended for working capital, and the sales will be conducted under the company’s effective Registration Statement, with Roth Capital Partners acting as the sales agent.
The most recent analyst rating on (MOBX) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Mobix Labs stock, see the MOBX Stock Forecast page.
On September 3, 2025, Mobix Labs, Inc. announced a warrant exercise inducement agreement with a holder of existing warrants, resulting in the exercise of warrants to purchase 5,486,467 shares of common stock, generating approximately $4.5 million in gross proceeds. The company will issue new warrants for 8,229,701 shares, exercisable upon stockholder approval, with Roth Capital Partners acting as financial advisor. The transaction is expected to close on September 4, 2025, and the proceeds will be used for working capital and general corporate purposes.
The most recent analyst rating on (MOBX) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Mobix Labs stock, see the MOBX Stock Forecast page.
Mobix Labs, Inc. completed a series of financing transactions on August 13 and 15, 2025, to strengthen its working capital and financial flexibility. The company secured $550,000 through a Securities Purchase Agreement with Lendspark Corporation, issuing a promissory note and Class A common stock as commitment shares. Additionally, Mobix Labs entered into a Business Loan and Security Agreement with Maximcash Solutions LLC for $600,000, backed by all company assets. An accredited investor also purchased shares for approximately $1.0 million, with a warrant for additional shares. These transactions indicate Mobix Labs’ strategic efforts to bolster its financial standing and operational capacity.
The most recent analyst rating on (MOBX) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Mobix Labs stock, see the MOBX Stock Forecast page.
Mobix Labs, Inc., based in Irvine, California, is a company specializing in the design and development of advanced wireless and wired connectivity solutions, primarily serving sectors such as aerospace, defense, and medical industries. The company focuses on RF, switching, and EMI filtering technologies, with products including RF and mmWave 5G communications systems and True Xero active optical cables.
On August 8, 2025, Mobix Labs, Inc. appointed Philip Sansone as a Class I director of the Board, effective immediately, with a term expiring at the 2028 Annual Meeting of Stockholders. Sansone, who has been serving as the CEO since July 2025, previously held the position of Interim CEO and Vice President of Worldwide Sales at Mobix Labs. On August 13, 2025, Sansone personally guaranteed a $600,000 loan to the company, highlighting his commitment to the company’s financial stability.
On July 23, 2025, Mobix Labs, Inc. announced the resignation of its CEO, Fabian Battaglia, effective July 25, 2025. Battaglia will continue as a senior advisor and board member until the end of 2026, with no disagreements cited as the reason for his departure. Concurrently, Philip Sansone was appointed as the new CEO, bringing extensive experience in worldwide sales and distribution from his previous roles, including his recent position as Interim CEO and Vice President of Worldwide Sales at Mobix Labs.